Physician

Adeem Akbar, M.D.

According to 2025 Medicare claims, Adeem Akbar, M.D. (NPI: 1790929867) practices nephrology, with the plurality of this provider's patient population coming from Monroe, PA. This provider's primary affiliated billing organization is ST. LUKE'S PHYSICIAN GROUP, INC (NPI: 1134581309) and primary practice location at 18360-6217. Akbar is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560), participating under the MSSP model.

Akbar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 446 traditional Medicare patients, billed 2,164 HCPCS/CPT codes, and received $156,944 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,651 prescription claims across 321 beneficiaries totaling $141,696 in drug costs, led by Jardiance (Empagliflozin). DME data shows 27 claims. Open Payments data shows 6 records totaling $572. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $94,561 to $156,944. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $96,273 to $141,696. For DME billing, this smaller-volume category fell sharply in recent years, from $1,710 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$109K$217K2015 Medicare payment: $94,561 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $108,151 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $158,417 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $105,897 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $168,830 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $205,210 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $217,229 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $181,218 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $166,226 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $156,944 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153881,173$94,561
20163581,214$108,151
20173941,462$158,417
20184081,142$105,897
20195381,757$168,830
20205162,018$205,210
20214772,090$217,229
20224551,910$181,218
20234601,775$166,226
20244462,164$156,944

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$116K$233K2015 Drug cost: $96,273 (USD; Tot_Drug_Cst)2016 Drug cost: $198,929 (USD; Tot_Drug_Cst)2017 Drug cost: $232,965 (USD; Tot_Drug_Cst)2018 Drug cost: $124,760 (USD; Tot_Drug_Cst)2019 Drug cost: $46,592 (USD; Tot_Drug_Cst)2020 Drug cost: $56,920 (USD; Tot_Drug_Cst)2021 Drug cost: $107,526 (USD; Tot_Drug_Cst)2022 Drug cost: $114,170 (USD; Tot_Drug_Cst)2023 Drug cost: $104,855 (USD; Tot_Drug_Cst)2024 Drug cost: $141,696 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151571,075$96,273
20161701,507$198,929
20171761,704$232,965
20181781,302$124,760
2019239753$46,592
20202281,045$56,920
20212891,324$107,526
20223231,531$114,170
20233361,654$104,855
20243211,651$141,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.6K$5.2K2015 Medicare payment: $356 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,140 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,680 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,156 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,793 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,162 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $890 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $917 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $82 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $710 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$356
2016N/R38$2,140
2017N/R23$1,680
2018N/R61$2,156
2019N/R40$3,793
2020N/R92$5,162
2021N/R37$890
2022N/R39$917
2023N/R12$82
2024N/R27$710

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes8086$137
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4995$92
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more237317$88
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes159444$62
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's195235$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin281,620$31,207
VelphoroSucroferric Oxyhydroxide11240$29,868
Sevelamer CarbonateSevelamer Carbonate311,803$7,399
Calcium AcetateCalcium Acetate653,648$5,816
Nifedipine ErNifedipine544,575$2,372

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7507Tacrolimus, immediate release, oral, 1 mgNN/R14$459
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R13$251

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$572Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adeem Akbar, M.D.?

Tedicare shows public-source Medicare data for Adeem Akbar, M.D. (NPI 1790929867), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adeem Akbar, M.D. have ACO affiliation data?

Adeem Akbar, M.D. is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560).

What billing organization is linked to Adeem Akbar, M.D.?

Adeem Akbar, M.D. is linked to ST. LUKE'S PHYSICIAN GROUP, INC (billing NPI 1134581309) in the available physician profile data.

Does Adeem Akbar, M.D. have Open Payments data?

Adeem Akbar, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.